Biotech & Pharma

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more

32 sec read8 views0 listens

The nonprofit Blood Cancer United has acquired the remaining supplies and investigational rights for the discontinued drug Luvelta to continue providing it to children with rare blood cancers. This unusual move highlights a critical shift in the pharmaceutical landscape where nonprofits are stepping in to rescue promising therapies abandoned by commercial entities during strategic pivots. Simultaneously, a recent data breach at Novo Nordisk involving clinical trial participants underscores the urgent need for enhanced cybersecurity measures to protect sensitive patient health information.

Read the full article at STAT Pharma

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

SonoThera has secured $125 million in Series B financing to advance its ultrasound-mediated genetic medicine platform toward clinical trials. This development is significant for the biotech sector because the proprietary RIPPLE and PORE technologies ...

Ali Nemati

Cybersecurity1 day ago31 sec read

Ramnit Blue Team Lab (CyberDefenders)

A cybersecurity lab exercise involves analyzing a memory dump from a potentially compromised workstation to identify and mitigate Ramnit malware. Participants must trace the suspicious process, locate its file path, determine network connections, and...

Ali Nemati

Biotech & Pharma2 days ago30 sec read

In Silico Devices May Improve Drug Manufacturability

In silico tools, particularly AI-driven predictive models, can significantly improve drug manufacturability by identifying potential issues early in the development process. BigHat Biosciences demonstrates that by augmenting physical experiments with...

Ali Nemati

Biotech & Pharma2 days ago30 sec read

10x Genomics Acquires Proteintech Genomics, Expanding Proteomics Capablities

10x Genomics has acquired Proteintech Genomics to integrate high-plex protein detection capabilities into its existing single-cell and spatial biology platforms. This acquisition matters to biotech professionals as it enables the harmonization of RNA...

Ali Nemati

Health & Medicine2 days ago27 sec read

STAT+: Pharmalittle: We're reading about U.S. pressure on European drug prices, longer shortages, and more

The number of prescription drug shortages in the U.S. has decreased overall but the duration of existing shortages has significantly increased, now averaging over five years. Concurrently, European countries are facing divergent approaches to drug pr...

Ali Nemati

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more

Related Articles

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Ramnit Blue Team Lab (CyberDefenders)

In Silico Devices May Improve Drug Manufacturability

10x Genomics Acquires Proteintech Genomics, Expanding Proteomics Capablities

STAT+: Pharmalittle: We're reading about U.S. pressure on European drug prices, longer shortages, and more